GSK (GSK.L) Stock Price
£1389 0%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
4 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on GSK, AI stock picks, stock alerts and much more.
GSK.L AI Stock Analysis
AI stock analysis for GSK.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like GSK (GSK.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
GSK (GSK.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of GSK (GSK.L), currently trading at £1389, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About GSK.L
-
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally.
-
Symbol
GSK.L
-
Market
LSE
-
Industry
Drug Manufacturers - General
-
Market Cap
56.3B
Similar Stocks
 |
AstraZeneca PLC AZN.L |
£10400 0.4% |
6 |
 |
Roche Holding AG 0QQ6.L |
CHF279.4 1.4% |
6 |
News
GSK.L Alternative Data
Web Traffic
GSK receives an estimated 1.2M monthly visitors to gsk.com.
-
Web Traffic
1214946
-
Change from Previous Month
21.7%
-
3 Month Change
59.1%
-
YoY Change
59.1%
Twitter Followers
GSK has 237,750 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.2% over the last month.
-
Twitter Followers
237750
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.6%
Facebook Engagement
GSK has engaged 1,162 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
1162
-
Daily Change
9.5%
-
1 Month Change
40.1%
-
3 Month Change
388.2%
Instagram Followers
GSK has 103,606 Instagram Followers on its main Instagram account, up by 0.7% over the last month.
-
Instagram Followers
103606
-
Daily Change
0.1%
-
1 Month Change
0.7%
-
3 Month Change
1.4%
Youtube Subscribers
GSK has 64,901 subscribers on its main Youtube channel, up by 0.9% over the last month.
-
Youtube Subscribers
64901
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
3.2%
App Downloads
-
App Downloads
156
-
Daily Change
0%
-
1 Month Change
32.8%
-
3 Month Change
500%
Job Postings
GSK currenly has an estimated 1,000 open job postings.
-
Job Postings
1000
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
GSK has been mentioned an estimated 1 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
News Mentions
GSK was mentioned 17 times in the news yesterday.
-
News Mentions
17
-
Daily Change
54.5%
-
1 Month Change
5.6%
-
3 Month Change
0%
LinkedIn Followers
4,273,852 are following GSK on LinkedIn, up by 0.6% over the last month.
-
LinkedIn Followers
4273852
-
Daily Change
0%
-
1 Month Change
0.6%
-
3 Month Change
2%
LinkedIn Employees
According to LinkedIn, GSK has 98,323 employees.
-
LinkedIn Employees
98323
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
1.1%
Business Outlook
According to employee reviews, the business outlook among employees at GSK is 62 out of 100 (bullish).
-
Business Outlook
62
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
GSK.L Financials
GSK.L Key Metrics
-
Total Revenue
£8.1B
-
Net Income
£414M
-
Earnings per Share
£0.1
-
Free cash flow
£1.2B
-
EBITDA
£1.1B
-
EBITDA Ratio
0.137859
-
Total Assets
£59.5B
GSK.L 2-year Revenue & Income
GSK.L 2-year Free Cash Flow
GSK.L Technicals
GSK.L SMA
GSK.L RSI
FAQ
What's the current price of GSK (GSK.L) Stock?
The price of an GSK (GSK.L) share is £1389.
What's the market cap of GSK?
The current market cap of GSK is 56.3B.
Should I buy or sell GSK.L?
GSK shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, GSK is better viewed as a hold or accumulate position while waiting for further developments.
Is GSK a good investment?
The current analysis of GSK's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in GSK's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy GSK (GSK.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for GSK stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to GSK (GSK.L) that investors often compare it to?
GSK (GSK.L) is often compared to similar stocks such as AstraZeneca PLC and Roche Holding AG.
What is the forecast for GSK's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast GSK's stock price to be around £1343 in 2026. Starting from the current price of £1389, this represents a 3.3% change in price, indicating a neutral outlook for the stock.
How to buy GSK (GSK.L) Stock?
GSK stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy GSK shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.